DalsnaFinance › Analyst accuracy › UBS › BSX target
UBS lowers Boston Scientific stock price target on valuation reset
UBS lowered its price target on Boston Scientific Corp. to $74 from $95 while maintaining a Buy rating on the stock.
A fact about what UBS published, as reported by Investing.com, not a recommendation from Dalsna Finance; UBS is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.